pantoprazole has been researched along with Health Care Associated Infection in 3 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stress ulcer prophylaxis (SUP) using ranitidine, a histamine H2 receptor antagonist, has been associated with an increased risk of ventilator-associated pneumonia." | 3.75 | Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients. ( Bowton, DL; Houle, TT; Kincaid, EH; MacGregor, DA; Miano, TA; Reichert, MG, 2009) |
| "Pantoprazole was the most commonly prescribed drug and appeared in 63% of all orders." | 1.62 | Pattern of systemic antibiotic use and potential drug interactions: Evaluations through a point prevalence study in Ankara University Hospitals. ( Akdemir Kalkan, İ; Akyol, B; Azap, A; Çınar, G; Memikoğlu, KO; Onay Beşikçi, A; Pehlivanlı, A; Topaloğlu, İE; Ürkmez, F, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Schefold, JC | 1 |
| Krag, M | 1 |
| Marker, S | 1 |
| Perner, A | 1 |
| Wetterslev, J | 1 |
| Wise, MP | 1 |
| Borthwick, M | 1 |
| Bendel, S | 1 |
| Keus, F | 1 |
| Guttormsen, AB | 1 |
| Lange, T | 1 |
| Møller, MH | 1 |
| Akdemir Kalkan, İ | 1 |
| Çınar, G | 1 |
| Pehlivanlı, A | 1 |
| Ürkmez, F | 1 |
| Topaloğlu, İE | 1 |
| Akyol, B | 1 |
| Onay Beşikçi, A | 1 |
| Azap, A | 1 |
| Memikoğlu, KO | 1 |
| Miano, TA | 1 |
| Reichert, MG | 1 |
| Houle, TT | 1 |
| MacGregor, DA | 1 |
| Kincaid, EH | 1 |
| Bowton, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sup-Icu RENal (SIREN) - a Sub-analysis of the Prospective SUP (Stress Ulcer Prophylaxis)-ICU Trial on the Risk of GI- Bleeding in ICU Patients Receiving Renal Replacement Therapy[NCT02718261] | Phase 4 | 3,350 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pantoprazole and Health Care Associated Infection
| Article | Year |
|---|---|
Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
Topics: Acute Kidney Injury; Aged; Clostridium Infections; Critical Care; Cross Infection; Female; Gastroint | 2019 |
2 other studies available for pantoprazole and Health Care Associated Infection
| Article | Year |
|---|---|
Pattern of systemic antibiotic use and potential drug interactions: Evaluations through a point prevalence study in Ankara University Hospitals.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Child; Comorbidity; Cross Infection; Cr | 2021 |
Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Distribution; Aged; Anti-Ulcer Agents; Area Unde | 2009 |